Rowlandmiller & Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-895
Closed -$100K 186
2024
Q3
$100K Buy
+895
New +$89.5K 0.02% 184
2022
Q2
Sell
-935
Closed -$105K 180
2022
Q1
$105K Hold
935
0.02% 186
2021
Q4
$113K Buy
+935
New +$104K 0.03% 178
2017
Q1
Sell
-1,677
Closed -$126K 129
2016
Q4
$126K Hold
1,677
0.06% 115
2016
Q3
$113K Hold
1,677
0.05% 114
2016
Q2
$115K Sell
1,677
-410
-20% -$30.1K 0.05% 116
2016
Q1
$151K Hold
2,087
0.07% 110
2015
Q4
$136K Hold
2,087
0.07% 111
2015
Q3
$135K Sell
2,087
-160
-7% -$11.8K 0.07% 109
2015
Q2
$184K Buy
2,247
+532
+31% +$41K 0.09% 105
2015
Q1
$116K Buy
1,715
+50
+3% +$3.61K 0.06% 120
2014
Q4
$126K Buy
+1,665
New +$132K 0.06% 113

Other funds holding EMN

Rowlandmiller & Partners's EMN Position: Q4 2024 in Review

Rowlandmiller & Partners sold out of Eastman Chemical (EMN) in Q4 2024, closing a stake of 895 shares — an estimated $100K sold.

Rowlandmiller & Partners first reported a position in EMN in Q4 2014 and held it in 12 quarters. The position peaked at $184K in Q2 2015. 786 funds tracked by Wall St. Rank hold EMN as of Q4 2024.

  • Rowlandmiller & Partners reported no remaining Eastman Chemical position as of Q4 2024 after selling out during the quarter.
  • Rowlandmiller & Partners sold 895 Eastman Chemical shares in Q4 2024, an estimated $100K.
  • Rowlandmiller & Partners first reported a position in Eastman Chemical in Q4 2014 and held it in 12 quarters.
  • Rowlandmiller & Partners's Eastman Chemical position peaked at $184K in Q2 2015.
  • 786 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2024.

Based on Rowlandmiller & Partners's 13F filing for Q4 2024, filed 4 Feb 2025.